Semantic Scholar uses AI to extract papers important to this topic.
Purpose: Velafermin (recombinant human fibroblast growth factor-20, rhFGF-20) has been shown to reduce the severity and duration… Expand (-)-Epigallocatechin gallate, 501516, 89-12; Abatacept, Adalimumab, Adefovir dipivoxil, AG-701, Agatolimod sodium, Alefacept… Expand Goals of workThe objective of this study was to evaluate the safety and tolerability of velafermin in patients at risk of… Expand Mucositis is a common, costly and unpleasant side effect of cancer chemotherapy and radiotherapy. Velafermin (FGF-20) has shown… Expand Oral mucositis (OM) is a commonly occurring side effect in patients (pts) undergoing AHSCT. Velafermin, recombinant human… Expand AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA
Oral mucositis is a debilitating side effect of chemotherapy and… Expand 6537 Background: Oral mucositis (OM) is a commonly occurring side effect of high-dose chemotherapy (HDCT) in patients (pts… Expand Objective:To express and purify bioactive recombinant human fibroblast growth factor-20(rhFGF-20)protein and to prepare its… Expand CuraGen is developing velafermin (CG-53135), human fibroblast growth factor-20 administered intravenously, for the potential… Expand Oral mucositis (OM) is a treatment-limiting condition associated with myelosupressive chemotherapy and radiation therapy. The… Expand